Biologic Activity of a Novel Heat Shock Protein 90 Inhibitor, PF-4928473, in Human Breast Cancer Cell Lines

被引:0
|
作者
Tsang, R. Y.
Conklin, D.
Kalous, O.
Desai, A.
Dering, J.
Ginther, C.
Christensen, J.
Slamon, D. J.
Finn, R. S.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Pfizer Global Res & Dev, La Jolla, CA USA
关键词
D O I
10.1158/0008-5472.SABCS10-P6-15-13
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-15-13
引用
收藏
页数:1
相关论文
共 50 条
  • [21] A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
    Jhaveri, Komal
    Chandarlapaty, Sarat
    Lake, Diana
    Gilewski, Teresa
    Robson, Mark
    Goldfarb, Shari
    Drullinsky, Pamela
    Sugarman, Steven
    Wasserheit-Leiblich, Carolyn
    Fasano, Julie
    Moynahan, Mary Ellen
    D'Andrea, Gabriella
    Lim, Kristina
    Reddington, Laura
    Haque, Sofia
    Patil, Sujata
    Bauman, Lynne
    Vukovic, Vojo
    El-Hariry, Iman
    Hudis, Clifford
    Modi, Shanu
    CLINICAL BREAST CANCER, 2014, 14 (03) : 154 - 160
  • [22] Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non-Small-Cell Lung Cancer
    Sequist, Lecia V.
    Gettinger, Scott
    Senzer, Neil N.
    Martins, Renato G.
    Jaenne, Pasi A.
    Lilenbaum, Rogerio
    Gray, Jhanelle E.
    Iafrate, A. John
    Katayama, Ryohei
    Hafeez, Nafeeza
    Sweeney, Jennifer
    Walker, John R.
    Fritz, Christian
    Ross, Robert W.
    Grayzel, David
    Engelman, Jeffrey A.
    Borger, Darrell R.
    Paez, Guillermo
    Natale, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) : 4953 - 4960
  • [23] Investigation of the role of quercetin as a heat shock protein inhibitor on apoptosis in human breast cancer cells
    Kiyga, Ezgi
    Sengelen, Aslihan
    Adiguzel, Zelal
    Onay Ucar, Evren
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (07) : 4957 - 4967
  • [24] Investigation of the role of quercetin as a heat shock protein inhibitor on apoptosis in human breast cancer cells
    Ezgi Kıyga
    Aslıhan Şengelen
    Zelal Adıgüzel
    Evren Önay Uçar
    Molecular Biology Reports, 2020, 47 : 4957 - 4967
  • [25] Potent activity of a novel dimeric heat shock protein 90 inhibitor against head and neck squamous cell carcinoma in vitro and in vivo
    Yin, XY
    Zhang, H
    Burrows, F
    Lin, Z
    Shores, CG
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3889 - 3896
  • [26] Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor
    Vesci, Loredana
    Milazzo, Ferdinando Maria
    Carollo, Valeria
    Pace, Silvia
    Giannini, Giuseppe
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1421 - 1429
  • [27] 17-allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels
    Braga-Basaria, M
    Hardy, E
    Gottfried, R
    Burman, KD
    Saji, M
    Ringel, MD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 2982 - 2988
  • [28] Inhibition of Heat Shock Protein 90 as a Novel Platform for the Treatment of Cancer
    Gao, Chan
    Peng, Ya-Nan
    Wang, Hai-Zhou
    Fang, Shi-Lin
    Zhang, Meng
    Zhao, Qiu
    Liu, Jing
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (08) : 849 - 855
  • [29] Antiproliferative activity of fish protein hydrolysates on human breast cancer cell lines
    Picot, L
    Bordenave, S
    Didelot, S
    Fruitier-Arnaudin, I
    Sannier, F
    Thorkelsson, G
    Bergé, JP
    Guérard, F
    Chabeaud, A
    Piot, JM
    PROCESS BIOCHEMISTRY, 2006, 41 (05) : 1217 - 1222
  • [30] Design, Synthesis, and Evaluation of Heat Shock Protein 90 Inhibitors in Human Breast Cancer and Its Metastasis
    Gumus, Mehmet
    Ozgur, Aykut
    Tutar, Lutfi
    Disli, Ali
    Koca, Irfan
    Tutar, Yusuf
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2016, 17 (14) : 1231 - 1245